Back to search
FDAFDA · Food and drugs·Recall number D-0812-2021

Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99

Published September 29, 2021 · Recall initiated: September 9, 2021

Summary

FDA records drug Class II recall D-0812-2021, published September 29, 2021 and initiated September 9, 2021. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 2,820 bottles; Lot: Lot: MJ1019025-A, Exp. date 04/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.

What to do

Voluntary: Firm initiated · Letter

Get an email if METOPROLOL TARTRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL TARTRATE
Manufacturer
Aurobindo Pharma USA Inc.
Distributor
Nationwide within the United States
Lot
Lot: MJ1019025-A, Exp. date 04/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99 recalled?

Yes. FDA published recall D-0812-2021 on September 29, 2021. Reported hazard: Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL TARTRATE.